SEC Form 4 · accession 0001209191-15-056805
ROCKET PHARMACEUTICALS, INC. · RCKT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Southwell
Officer — See Remarks · Director
Period of report
Jun 24, 2015
Accepted (ET)
Jun 26, 2015 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001281895
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $5.03 | Jun 24, 2015 | A | 150,000 | A | — | Jun 23, 2025 | Common Stock | 150,000 | 548,497 | D |
Explanation of responses
- F1The stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan. 25% of the options granted shall vest on the one year anniversary of February 17, 2015 and 1/36th of the remaining option grant shall vest on each monthly anniversary thereafter, subject to continued service through such dates.
Remarks
Exhibit List Exhibit 24 - Power of Attorney President and Chief Executive Officer